These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1146833)
1. Use of bioavailability data by practitioners. I: pitfalls in interpreting the data. Schumacher GE Am J Hosp Pharm; 1975 Aug; 32(8):639-42. PubMed ID: 1146833 [TBL] [Abstract][Full Text] [Related]
2. An overview of the analysis and interpretation of bioavailability studies in man. Wagner JG Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the clinical inequivalency of drug products of varying bioavailability. Barr WH; Adir J Ann Clin Res; 1974; 6(0):suppl 11:48-56. PubMed ID: 4605465 [No Abstract] [Full Text] [Related]
4. The potential clinical significance of differences in bioavailability. Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482 [No Abstract] [Full Text] [Related]
5. [Clinical questions on bioavailability and proff of efficacy (author's transl)]. Gillmann H Arzneimittelforschung; 1976; 26(1A):103-4. PubMed ID: 947189 [TBL] [Abstract][Full Text] [Related]
6. Interpretation of bioavailability data by practitioners. Schumacher GE J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):554-9. PubMed ID: 977795 [No Abstract] [Full Text] [Related]
7. [Bioavailability and its significance in pharmacotherapy]. Wiela-HojeĊska A; Orzechowska-Juzwenko K Pol Merkur Lekarski; 2003 Jan; 14(79):89-93. PubMed ID: 12712840 [TBL] [Abstract][Full Text] [Related]
8. Recognition of variable bioavailability as an international problem: a review of the earlier studies. Munro-Faure AD; Fowle AS; Fox J; Johnson BF; Lader S Postgrad Med J; 1974 Nov; 50 Suppl 6():14-8. PubMed ID: 4459882 [No Abstract] [Full Text] [Related]
9. The importance of bioavailability to the pharmacist. Canada AT Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):346-8. PubMed ID: 1158541 [TBL] [Abstract][Full Text] [Related]
10. The pharmacist's ability to use bioavailability data. Cronk JD; Williams RB; Moore WE Am J Hosp Pharm; 1975 Jan; 32(1):46-8. PubMed ID: 1124781 [TBL] [Abstract][Full Text] [Related]
11. Bioavailability: some pharmaceutical factors. Fowle AS Trans Med Soc Lond; 1975; 91():23-32. PubMed ID: 1236035 [No Abstract] [Full Text] [Related]
12. Statistical inference as applied to bioavailability data--a guide for the practicing pharmacist. Bennett RW; Popovich NG Am J Hosp Pharm; 1977 Jul; 34(7):712-23. PubMed ID: 578074 [TBL] [Abstract][Full Text] [Related]
13. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Dokoumetzidis A; Macheras P Int J Pharm; 2006 Sep; 321(1-2):1-11. PubMed ID: 16920290 [TBL] [Abstract][Full Text] [Related]
14. Letter: Drug bioavailability. Ruedy J; Davies RO; Gagnon MA; McLean WM; Thompson WG; Vitti TG; Wilson TW Can Med Assoc J; 1976 Jul; 115(2):105. PubMed ID: 1277067 [No Abstract] [Full Text] [Related]
15. [Biological availability of digoxin in combination drugs]. Gilfrich HJ; Clasen R Verh Dtsch Ges Inn Med; 1975; 81():1666-9. PubMed ID: 1227052 [No Abstract] [Full Text] [Related]
16. [Bioavailability of digoxin tablets in Israel]. Levy M; Adler R; Superstein E; Eliakim M Harefuah; 1975 Aug; 89(4):153-4. PubMed ID: 1158280 [No Abstract] [Full Text] [Related]
17. Comparative bioavailability of drug products: principles, design of study and data analysis. Nanivadekar AS; Gupta PD; Kulkarni SS Indian J Med Res; 1976 Apr; 64(4):545-53. PubMed ID: 786872 [No Abstract] [Full Text] [Related]